Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: Influence of formulation factors on the lymphatic targeting

International Journal of Pharmaceutics

Volumn 471, Issue 1-2, 2014, Pages 245-257

  Tiantian, Ye ^a   Wenji, Zhang ^a   Mingshuang, Sun ^a   Rui, Yang ^a   Shuangshuang, Song ^a   Yuling, Mao ^a   Jianhua, Yao ^a   Xinggang, Yang ^a   Shujun, Wang ^a   Weisan, Pan ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Hyaluronic acid; Liposome; Lymph node uptake; Lymphatic drainage; Lymphatic targeting; Subcutaneous administration

Indexed keywords

DOCETAXEL; HYALURONIC ACID; LIPOSOME; ANTINEOPLASTIC AGENT; DRUG CARRIER; NANOPARTICLE; TAXOID;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG RETENTION; DRUG TARGETING; DRUG UPTAKE; FLUORESCENCE IMAGING; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE; LYMPH NODE UPTAKE; LYMPHATIC DRAINAGE; LYMPHATIC SYSTEM; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PARTICLE SIZE; PHARMACOKINETICS; PHYSICAL CHEMISTRY; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; STATIC ELECTRICITY; ZETA POTENTIAL; ANIMAL; CHEMISTRY; DEVICES; DRUG STABILITY; EQUIPMENT DESIGN; INBRED MOUSE STRAIN; METABOLISM; PROCEDURES; SUBCUTANEOUS DRUG ADMINISTRATION; SURFACE PROPERTY; TISSUE DISTRIBUTION;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG LIBERATION; DRUG STABILITY; EQUIPMENT DESIGN; HYALURONIC ACID; INJECTIONS, SUBCUTANEOUS; LIPOSOMES; LYMPH NODES; MALE; MICE, INBRED STRAINS; NANOPARTICLES; PARTICLE SIZE; SURFACE PROPERTIES; TAXOIDS; TISSUE DISTRIBUTION;

EID: 84901819493     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.05.027     Document Type: Article

References (45)

1. T.M. Allen, C.B. Hansen, and L.S.S. Guo Subcutaneous administration of liposomes: a comparison with the intravenousand intraperitoneal routes of injection BBA-Biomembranes 1150 1993 9 16 (Pubitemid 23220825)
2. S. Arpicco, C. Lerda, E. Dalla Pozza, C. Costanzob, N. Tsapisc, B. Stella, M. Donadellib, I. Dandob, E. Fattalc, L. Cattela, and M. Palmierib Hyaluronic acid-coated liposomes for active targeting of gemcitabine Eur. J. Pharm. Biopharm. 85 2013 373 380
3. U. Bettendorf Electronmicroscopicstudies on the peritoneal resorption ofintraperitoneally injected latex particlesvia the diaphragmatic lymphatics Lymphology 12 1979 66 70
4. S. Cai, Q. Yang, T.R. Bagby, and M.L. Forrest Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles Adv. Drug. Deliv. Rev. 63 2011 901 908
5. J.R. Casley-Smith The fine structure and functioning of tissue channels and lymphatics Lymphology 13 1980 177
6. K.Y. Choi, K.H. Min, H.Y. Yoon, K. Kim, J.H. Park, and I.C. Kwon et al. PEGylation of hyaluronic acid nanoparticles improves tumor target ability in vivo Biomaterials 32 2011 1880 1889
7. K.Y. Choi, G. Saravanakumar, J.H. Park, and K. Park Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteinsin cancer Colloids Surf. B 99 2012 82 94
8. P.H. Cox The kinetics of macromolecule transport in lymph and colloid accumulation in lymph nodes Prog. Radiopharmacol. 2 1981 267 292
9. J.D.F. De Campos, J.B. Da Silva, A.R.M. Beck, S.R. Secoli, and M.H. De Melo Lima Subcutaneous administration technique of low-molecular-weight heparins: an integrative review Clin. Nurs. Stud. 1 2013 36
10. G. Di Venosa, L. Hermida, A. Batlle, H. Fukuda, M.V. Defain, L. Mamone, and A. Casas Characterization of liposomes containing aminolevulinic acid and derived esters J. Photochem. Photobiol. B 92 2008 1 9 (Pubitemid 351944030)
11. J.R. Fraser, W.G. Kimpton, T.C. Laurent, R.N. Cahill, and N. Vakakis Uptake and degradation of hyaluronan in lymphatic tissue Biochem. J. 256 1988 153 158
12. J.R.E. Fraser, and T.C. Laurent Turnover and metabolism of hyaluronan Ciba Found. Symp. 143 1989 41 59
13. S. Ganesh, A.K. Iyer, D.V. Morrissey, and M.M. Amiji Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors Biomaterials 34 2013 3489 3502
14. M. Hanke, I. Hoffmann, C. Christophis, M. Schubert, V.T. Hoang, A. Zepeda-Moreno, N. Baran, V. Eckstein, P. Wuchter, A. Rosenhahn, and A.D. Ho Differences between healthy hematopoietic progenitors and leukemia cells with respect to CD44 mediated rolling versus adherence behavior on hyaluronic acid coated surfaces Biomaterials 35 2014 1411 1419
15. K.J. Harrington, G. Rowlinson-Busza, K.N. Syrigos, P.S. Uster, R.G. Vile, and J.S.W. Stewart Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery Clin. Cancer Res. 6 2000 2528 2537 (Pubitemid 30399225)
16. K.J. Harrington, G. Rowlinson-Busza, K.N. Syrigos, P.S. Uster, R.M. Abra, and J.S.W. Stewart Biodistribution and pharmacokinetics of 111 in-DTPA-labelled pegylated liposomes in a human tumor xenograft model: implications for novel targeting strategies Brit. J. Cancer 83 2000 232
17. A.E. Hawley, S.S. Davis, and L. Illum Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics Adv. Drug Deliv. Rev. 17 1995 129 148
18. K. Hirano, C.A. Hunt, A. Strubbe, and R.D. MacGregor Lymphatic transport of liposome-encapsulated drugs following intraperitoneal administration-effect of lipid composition Pharm. Res. 2 1985 271 278 (Pubitemid 16193198)
19. M. Kusano, Y. Tajima, K. Yamazaki, M. Kato, M. Watanabe, and M. Miwa Sentinel node mapping guided byindocyanine green fluorescence imaging: a new method for sentinel node navigation surgery in gastrointestinal cancer Digest. Surg. 25 2008 103 108 (Pubitemid 351748763)
20. D. Kumer, R.S. Tomar, S.K. Deolia, M. Mitra, R. Mukherjee, and A.C. Burman Isolation and characterization of degradation impurities in docetaxel drug substance and its formulation J. Pharmaceut. Biomed. 43 2007 1228 1235
21. C. Laurich, M.A. Wheeler, J. Iida, C.L. Neudauer, J.B. McCarthy, and K.M. Bullard Hyaluronan mediated adhesion of metastatic colon carcinoma cells J. Surg. Res. 122 2004 70 74 (Pubitemid 39441235)
22. C.H. Lee, S.H. Cheng, Y.J. Wang, Y.C. Chen, N.T. Chen, J. Souris, C.T. Chen, C.Y. Mou, C.S. Yang, and L.W. Lo Near-infrared mesoporous silica nanoparticles for optical imaging: characterization and in vivo biodistribution Adv. Funct. Mater. 19 2009 215 222
23. Q. Li, H. Wang, Y. Tan, and Y. Wang Distribution of hyaluronan in macrophages and effects of hyaluronan on adhesion and migration of the cells Acta Anatomica Sinica 35 2003 152 156
24. M.L. Manca, M. Manconi, D. Valentil, F. Lai, G. Loy, P. Matricardi, and A.M. Fadda Liposomes coated with chitosan-xanthan gum (chitosomes) as potential carriers for pulmonary delivery of rifampicin J. Pharm. Sci. 101 2012 566 575
25. T.A. McDonald, M.L. Zepeda, M.J. Tomlinson, W.H. Bee, and I.A. Ivens Subcutaneous administration of biotherapeutics: current experience in animal models Curr. Opin. Mol. Ther. 12 2010 461 470
26. S.M. Moghimi, A.E. Hawley, N.M. Christy, T. Gray, L. Illum, and S.S. Davis Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes FEBS Lett. 344 1994 25 30 (Pubitemid 24147300)
27. T. Musumeci, L. Vicari, C.A. Ventura, M. Gulisano, R. Pignatello, and G. Puglisi Lyoprotected nanosphere formulations for paclitaxel controlled delivery J. Nanosci. Nanotechnol. 6 2006 9 10
28. ®): PLGA nanoparticles containing vitamin E TPGS J. Control. Release 86 2003 33 48 (Pubitemid 35469120)
29. S. Naik, D. Patel, N. Surti, and A. Misra Preparation of PEGylated liposomes of docetaxel using supercritical fluid technology J. Supercrit. Fluids 54 2010 110 119
30. Y. Nishioka, and H. Yoshino Lymphatic targeting with nanoparticulate system Adv. Drug Deliv. Rev. 47 2001 55 64 (Pubitemid 32209232)
31. C. Oussoren, and G. Storm Liposomes to target the lymphatics by subcutaneous administration Adv. Drug Deliv. Rev. 50 2001 143 156 (Pubitemid 32727280)
32. C. Oussoren, J. Zuidema, D.J.A. Crommelin, and G. Storm Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: II. Influence of liposomal size, lipid composition and lipid dose BBA-Biomembranes 1328 1997 261 272 (Pubitemid 27376453)
33. W.T. Phillips, R. Klipper, and B. Goins Novel method of greatly enhanced delivery of liposomes to lymph nodes J. Pharmcol. Exp. Ther. 295 2000 309 313
34. D. Peer, and R. Margalit Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal doxorubicin in syngeneic and human xenograft mouse tumor models Neoplasia 6 2004 343
35. M. Salmi, M. Karikoski, K. Elima, P. Rantakari, and S. Jalkanen CD44 binds to macrophage mannose receptor on lymphatic endothelium and supports lymphocyte migration via afferent lymphatics Circ. Res. 112 2013 1577 1582
36. J. Shen, C. Zhan, C. Xie, Q. Meng, B. Gu, C. Li, Y. Zhang, and W. Lu Poly(ethylene glycol)-block-poly(d,l-lactide acid) micelles anchored with angiopep-2 for brain-targeting delivery J. Drug Target. 19 2011 197 203
37. I. Singh, R. Swami, W. Khan, and R. Sistla Lymphatic system: a prospective area for advanced targeting of particulate drug carriers Expert. Opin. Drug Del. 11 2014 211 229
38. S. Song, F. Chen, H. Qi, F. Li, T. Xin, J. Xu, T. Ye, N. Sheng, X. Yang, and W. Pan Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel Pharm. Res. 31 2013 1032 1045
39. D. Volodkin, H. Mohwald, J.C. Voegel, and V. Ball Coating of negatively chargedliposomes by polylysine: drug release study J. Control. Release 117 2007 111 120 (Pubitemid 46161871)
40. S. Wang, R. Yang, H. Yao, G. Zhou, Y. Zhang, B. Yang, N. Lawrence, and M.C. Yan In vivo lymphatic targeting of methylene blue with microemulsion and multiple microemulsion Drug Deliv. 16 2009 371 377
41. M. Wang, Y. Yuan, Y. Gao, H.M. Ma, H.T. Xu, X.N. Zhang, and W.S. Pan Preparation and characterization of 5-fluorouracil pH-sensitive niosome and its tumor-targeted evaluation: in vitro and in vivo Drug Dev. Ind. Pharm. 38 2012 1134 1141
42. Z.Q. Yan, F. Wang, Z.Y. Wen, C.Y. Zhan, L.L. Feng, Y. Liu, X.L. Wei, C. Xie, and W.Y. Lu LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor J. Control. Release 157 2012 118 125
43. X.Y. Yang, Y.X. Li, M. Li, L. Zhang, L.X. Feng, and N. Zhang Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer Cancer Lett. 334 2013 338 345
44. J.A. Yáñez, S.W. Wang, I.W. Knemeyer, M.A. Wirth, and K.B. Alton Intestinal lymphatic transport for drug delivery Adv. Drug Deliv. Rev. 63 2011 923 942
45. Y. Zhuang, Y. Ma, C. Wang, L. Hai, C. Yan, Y. Zhang, and L. Cai PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution J. Control. Release 159 2012 135 142